Homeostatic Microglial Collapse

The second volume of the Collapse Trilogy, and the corpus's account of Phase II. Its subject is a genuine impasse in the field, and its contribution is to dissolve rather than adjudicate it.

The impasse it addresses

Two causal frameworks in microglial biology have accumulated substantial, apparently incompatible support.

The attack model holds that chronically activated microglia drive neurodegeneration — complement-mediated synaptic pruning, matrix-metalloproteinase-driven degradation of the extracellular matrix, NLRP3 inflammasome activation, sustained cytokine release — with TREM2-dependent disease-associated microglial (DAM) states as the destructive engine.

The failure model holds the opposite: that senescent, dystrophic and phagocytically exhausted microglia progressively withdraw support from vulnerable neurons, losing amyloid clearance, matrix maintenance and trophic sustenance of parvalbumin interneurons. On this reading the lesion is not microglial attack but microglial abandonment.

Each framework predicts results the other cannot explain. Each has produced a therapeutic programme whose clinical failure the other side reads as vindication.

The resolution

The thesis argues that attack and failure are not two phenomena but one, seen from two vantage points — the substrate's and the protected cell's. The single upstream event is the loss of the TGF-β/SMAD-maintained homeostatic microglial signature (P2RY12, TMEM119, CX3CR1, SALL1), which is not a label but a behavioural programme of surveillance and restrained pruning. Once that programme lapses, the cell enters one of several post-homeostatic trajectories — DAM, LDAM, dystrophic — pivoting through TREM2, and whether it then looks like an attacker or a deserter is a matter of local conditions rather than of cell fate.

The place where the two descriptions become the same description is the perineuronal net around the parvalbumin interneuron: a failed salvage attempt at the net is a proteolytic attack on it.

The human anchor

The thesis rests its human claim on the de Vries and Carulli resilience neuropathology, and that claim was corrected in July 2026. Resilient donors do not show preserved nets; they show a matrix that is remodelled rather than digested — reduced net density, reduced aggrecan, but without the matrix-proteolytic transcriptional programme (VCAN, ADAMTS2) that characterises the demented brain. See cognitive resilience for the corrected statement and research/CORPUS_ERRATA_2026-07.md item 1 for the evidence.

The microglial half of the framework survives that correction intact, and is in fact the half the paper supports most directly.

What it left unspecified

The thesis leaned on "metabolic fitness", "oxidative senescence" and "failed salvage" as load-bearing variables without naming the machinery those terms require. That vacancy is what Bioenergetic Collapse was written to fill.

Where to read it

The canonical treatment is research/collapse-trilogy/homeostatic-microglial/, whose supporting papers include Fischer's Matrix, the locus coeruleus transition, the Schwartz peripheral arm, the Stevens complement review, the Deczkowska DAM review and the Gate NLRP3 review. The narrative version is the Microglial monograph.

Related

Bioenergetic Collapse · Convergent Synaptic Collapse · Perineuronal Nets · cognitive resilience · Glial Biology · Neuroimmunology · Neuroimmune Interface